The virus early proteins have diverse regulatory functions during virus replication making them potentially excellent drug targets. The only enzyme expressed by HPV is E1, an ATP-dependent helicase ...
Cutaneous human papillomaviruses (HPVs)—skin-infecting relatives of the better-known mucosal HPVs—cause persistent infections that may contribute to skin cancers, especially in immunocompromised ...
BUFFALO, N.Y. – New research reveals that triggering a cell’s DNA damage response could be a promising avenue for developing novel treatments against several rare but devastating viruses for which no ...
Human papillomaviruses, or HPVs, cause cutaneous and mucosal infections that may lead to cancer. To date, no antiviral treatment options exist for HPVs. Researchers have identified a promising new ...
Human papillomaviruses, or HPVs, can cause dangerous infections in the skin and mucous membranes and may lead to cancer. Vaccines that prevent mucosal HPV infections aren't effective against cutaneous ...
Usually, it takes around 15–20 years for atypical cervical cells occurring from the human papillomavirus (HPV) to progress to cervical cancer. However, this can vary between individuals. Additionally, ...
University of Bristol provides funding as a founding partner of The Conversation UK. Few viruses are as widespread – and sometimes misunderstood – as the human papillomavirus, or HPV. It’s so common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback